Euphorbia Hirta

Bitki adı: Euphorbia Hirta
Bilimsel adı: Euphorbia hirta
Cins: Euphorbia
Familya: Euphorbiaceae

Genel Bilgiler


Duke – Ethnobotany

Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Martinez
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hunan
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb24: 253
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Woi.3
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb28: 13
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hunan
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb24: 253
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Woi.3
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hunan
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Woi.3
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb32: 305
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Woi.3
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb30: 401
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb30: 127
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hunan
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb32: 305
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb24: 253
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Altschul
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hunan
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb28: 13
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Standley,Steyermark
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hunan
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb30: 127
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb30: 127
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb24: 253
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hunan
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb32: 305
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Woi.3
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb30: 127
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hunan
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Standley,Steyermark
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb24: 253
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb30: 127
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Broun
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb28: 13
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb24: 253
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb32: 305
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hunan
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Standley,Steyermark
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb28: 13
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Martinez
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Woi.3
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb32: 305
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb32: 305
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb28: 13
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke

Bilimsel Araştırmalar

Phenolic compounds and flavonoids are potential substitutes for bioactive agents in pharmaceutical and medicinal sections to promote human health and prevent and cure different diseases. The most common flavonoids found in nature are anthocyanins, flavones, flavanones, flavonols, flavanonols, isoflavones, and other sub-classes. The impacts of plant flavonoids and other phenolics on human health promoting and diseases curing and preventing are antioxidant effects, antibacterial impacts, cardioprotective effects, anticancer impacts, immune system promoting, anti-inflammatory effects, and skin protective effects from UV radiation. This work aims to provide an overview of phenolic compounds and flavonoids as potential and important sources of pharmaceutical and medical application according to recently published studies, as well as some interesting directions for future research. The keyword searches for flavonoids, phenolics, isoflavones, tannins, coumarins, lignans, quinones, xanthones, curcuminoids, stilbenes, cucurmin, phenylethanoids, and secoiridoids medicinal plant were performed by using Web of Science, Scopus, Google scholar, and PubMed. Phenolic acids contain a carboxylic acid group in addition to the basic phenolic structure and are mainly divided into hydroxybenzoic and hydroxycinnamic acids. Hydroxybenzoic acids are based on a C6-C1 skeleton and are often found bound to small organic acids, glycosyl moieties, or cell structural components. Common hydroxybenzoic acids include gallic, syringic, protocatechuic, p -hydroxybenzoic, vanillic, gentistic, and salicylic acids. Hydroxycinnamic acids are based on a C6-C3 skeleton and are also often bound to other molecules such as quinic acid and glucose. The main hydroxycinnamic acids are caffeic, p -coumaric, ferulic, and sinapic acids.

Makaleyi görüntüle
Diabetes mellitus is one of the major health problems in the world, the incidence and associated mortality are increasing. Inadequate regulation of the blood sugar imposes serious consequences for health. Conventional antidiabetic drugs are effective, however, also with unavoidable side effects. On the other hand, medicinal plants may act as an alternative source of antidiabetic agents. Examples of medicinal plants with antidiabetic potential are described, with focuses on preclinical and clinical studies. The beneficial potential of each plant matrix is given by the combined and concerted action of their profile of biologically active compounds.

Makaleyi görüntüle
The era of antibiotic resistance is a cause of increasing concern as bacteria continue to develop adaptive countermeasures against current antibiotics at an alarming rate. In recent years, studies have reported nanoparticles as a promising alternative to antibacterial reagents because of their exhibited antibacterial activity in several biomedical applications, including drug and gene delivery, tissue engineering, and imaging. Moreover, nanomaterial research has led to reports of a possible relationship between the morphological characteristics of a nanomaterial and the magnitude of its delivered toxicity. However, conventional synthesis of nanoparticles requires harsh chemicals and costly energy consumption. Additionally, the exact relationship between toxicity and morphology of nanomaterials has not been well established. Here, we review the recent advancements in synthesis techniques for silver, gold, copper, titanium, zinc oxide, and magnesium oxide nanomaterials and composites, with a focus on the toxicity exhibited by nanomaterials of multidimensions. This article highlights the benefits of selecting each material or metal-based composite for certain applications while also addressing possible setbacks and the toxic effects of the nanomaterials on the environment.

Makaleyi görüntüle
Silver nanoparticles (NPs) have been the subjects of researchers because of their unique properties (e.g., size and shape depending optical, antimicrobial, and electrical properties). A variety of preparation techniques have been reported for the synthesis of silver NPs; notable examples include, laser ablation, gamma irradiation, electron irradiation, chemical reduction, photochemical methods, microwave processing, and biological synthetic methods. This review presents an overview of silver nanoparticle preparation by physical, chemical, and biological synthesis. The aim of this review article is, therefore, to reflect on the current state and future prospects, especially the potentials and limitations of the above mentioned techniques for industries.

Makaleyi görüntüle
Biomedical nanotechnology is an evolving field having enormous potential to positively impact the health care system. Important biomedical applications of nanotechnology that may have potential clinical applications include targeted drug delivery, detection/diagnosis and imaging. Basic understanding of how nanomaterials, the building blocks of nanotechnology, interact with the cells and their biological consequences are beginning to evolve. Noble metal nanoparticles such as gold, silver and platinum are particularly interesting due to their size and shape dependent unique optoelectronic properties. These noble metal nanoparticles, particularly of gold, have elicited a lot of interest for important biomedical applications because of their ease of synthesis, characterization and surface functionalization. Furthermore, recent investigations are demonstrating another promising application of these nanomaterials as self-therapeutics. To realize the potential promise of these unique inorganic nanomaterials for future clinical translation, it is of utmost importance to understand a few critical parameters; (i) how these nanomaterials interact with the cells at the molecular level; (ii) how their biodistribution and pharmacokinetics influenced by their surface and routes of administration; (iii) mechanism of their detoxification and clearance and (iv) their therapeutic efficacy in appropriate disease model. Thus in this critical review, we will discuss the various clinical applications of gold, silver and platinum nanoparticles with relevance to above parameters. We will also mention various routes of synthesis of these noble metal nanoparticles. However, before we discuss present research, we will also look into the past. We need to understand the discoveries made before us in order to further our knowledge and technological development (318 references).

Makaleyi görüntüle

Kaynaklar ve Görseller

« Euphorbia helioscopia Euphorbia humifusa »